"Ankylosing Spondylitis (AS) Market – Industry Trends and Forecast to 2028
Global Ankylosing Spondylitis (AS) Market By Drug Type (Non-steroidal Anti-Inflammatory Drugs, TNF Blockers, Immunosuppressive Drugs, Anti-Inflammatory Drugs, Steroids, JAK Inhibitors and Others), Application (Juveniles and Adults), Molecule (Biologics, Bio similar and Small Molecules), Route of Administration (Parenteral, Oral and Others), End User (Hospitals, Clinics, Research Laboratories and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Data Bridge Market Research analyses that the ankylosing spondylitis (AS) market will exhibit a CAGR of around 8.48% for the forecast period of 2021-2028. Increasing prevalence of ankylosing spondylitis (AS) globally, rising expenditure for research and development proficiencies and increasing public and private expenditure for the development of healthcare infrastructure especially in emerging economies are the major factors attributable to the growth of ankylosing spondylitis (AS) market.
Access Full 350-page PDF Report @
https://www.databridgemarketresearch.com/reports/global-ankylosing-spondylitis-as-market
Ankylosing spondylitis (AS) is an inflammatory disease that has an adverse impact on the spinal cord. Ankylosing spondylitis (AS) is a kind of arthritis that reduces the flexibility of spine. The inflammation results in excessive lower back pain that gradually shifts to upper spine, neck, and chest.
**Segments**
- Diagnosis: The diagnosis segment of the Ankylosing Spondylitis market covers various methods and tools used to diagnose AS, such as blood tests, imaging techniques like X-rays and MRI, physical exams, and symptom assessments. The increasing awareness regarding early diagnosis and treatment options is driving growth in this segment.
- Treatment: The treatment segment includes various options such as nonsteroidal anti-inflammatory drugs (NSAIDs), biologics, corticosteroids, physical therapy, and surgery. The demand for advanced treatment options with fewer side effects is propelling this segment.
- End-User: The end-user segment comprises hospitals, clinics, and research institutes. The increasing prevalence of AS and the rising healthcare infrastructure in developing regions are boosting the demand within this segment.
**Market Players**
- AbbVie Inc.: AbbVie is a prominent player in the Ankylosing Spondylitis market, offering biologic drugs such as Humira for the treatment of AS. The company focuses on research and development activities to introduce innovative therapies for better patient outcomes.
- Pfizer Inc.: Pfizer is actively involved in the development and commercialization of pharmaceutical products for AS treatment. The company's strong market presence and strategic collaborations contribute to its market share in the AS segment.
- Johnson Johnson: Johnson Johnson's pharmaceutical division, Janssen Biotech, markets biologic medications for AS treatment. The company's robust distribution network and focus on expanding its product portfolio help in strengthening its position in the Ankylosing Spondylitis market.
The Ankylosing Spondylitis (AS) market is witnessing significant growth due to the increasing prevalence of AS globally. Factors such as a growing geriatric population, rising awareness about AS, and advancements in diagnostic techniques are driving market expansion. Additionally, the availability of novel treatments, such as biologics and targeted therapies, is enhancing patient outcomes and driving market growth. The market is highly competitive, with key players investing in research and developmentThe Ankylosing Spondylitis (AS) market is a dynamic and competitive landscape driven by various factors influencing market trends and growth opportunities. One of the primary growth drivers for the AS market is the increasing prevalence of AS globally. As the incidence of AS continues to rise, fueled by factors such as genetic predisposition, environmental factors, and changes in lifestyle patterns, the demand for effective diagnostic tools, treatment options, and management strategies is also increasing. This surge in demand is creating lucrative opportunities for market players to introduce novel therapeutics and diagnostic technologies tailored to address the unmet needs of AS patients.
Furthermore, the growing geriatric population is contributing to the expansion of the AS market. Aging populations are more susceptible to AS, as the condition typically manifests between the ages of 17 and 45, with symptoms worsening over time if left untreated. With a larger proportion of older individuals worldwide, the prevalence of AS is expected to escalate, necessitating the development of targeted therapies and interventions to improve patient outcomes and quality of life.
Advancements in diagnostic techniques play a crucial role in driving market growth by enabling healthcare providers to accurately diagnose AS at an early stage. Blood tests, imaging modalities like X-rays and MRI scans, physical exams, and symptom assessments are vital tools used in the diagnosis of AS. The emphasis on early detection and intervention is gaining traction in the medical community, as timely diagnosis can lead to better disease management and improved prognosis for AS patients. This focus on early diagnosis is encouraging market players to invest in novel diagnostic technologies and tools that enhance the efficiency and accuracy of AS diagnosis.
In the treatment segment of the AS market, various options are available to manage the symptoms and progression of the disease. Nonsteroidal anti-inflammatory drugs (NSAIDs), biologics, corticosteroids, physical therapy, and surgery are among the commonly used treatment modalities for AS. The demand for advanced treatment options with improved efficacy and fewer side effects is fueling research and development efforts among market**Segments**
- Diagnosis: The diagnosis segment of the Ankylosing Spondylitis market is crucial as it involves various methods such as blood tests, imaging techniques, physical exams, and symptom assessments. Early diagnosis is essential for effective management of AS, driving growth in this segment as awareness increases.
- Treatment: The treatment segment offers various options including NSAIDs, biologics, corticosteroids, physical therapy, and surgery. Demand for advanced treatments with fewer side effects is propelling this segment forward.
- End-User: The end-user segment encompasses hospitals, clinics, and research institutes. The increasing prevalence of AS and growth in healthcare infrastructure in developing regions are boosting demand within this segment.
**Market Players**
- AbbVie Inc.: A key player offering biologic drugs like Humira for AS treatment, focusing on research and development for innovative therapies.
- Pfizer Inc.: Actively involved in developing and commercializing pharmaceutical products for AS treatment, leveraging strong market presence and collaborations.
- Johnson Johnson: Through Janssen Biotech, markets biologic medications for AS treatment, with a strong distribution network and enhanced product portfolio.
The Global Ankylosing Spondylitis (AS) Market exhibits significant growth opportunities with various drug types, applications, molecules, routes of administration, and end-users. The industry experiences a surge in demand driven by advancements in treatment options and diagnostic techniques, increasing awareness, and a rising geriatric population. The market is highly competitive, with key players aiming
Table of Content:
Part 01: Executive Summary
Part 02: Scope of the Report
Part 03: Global Ankylosing Spondylitis (AS) Market Landscape
Part 04: Global Ankylosing Spondylitis (AS) Market Sizing
Part 05: Global Ankylosing Spondylitis (AS) Market Segmentation by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
Objectives of the Report
- To carefully analyze and forecast the size of the Ankylosing Spondylitis (AS) market by value and volume.
- To estimate the market shares of major segments of the Ankylosing Spondylitis (AS)
- To showcase the development of the Ankylosing Spondylitis (AS) market in different parts of the world.
- To analyze and study micro-markets in terms of their contributions to the Ankylosing Spondylitis (AS) market, their prospects, and individual growth trends.
- To offer precise and useful details about factors affecting the growth of the Ankylosing Spondylitis (AS)
- To provide a meticulous assessment of crucial business strategies used by leading companies operating in the Ankylosing Spondylitis (AS) market, which include research and development, collaborations, agreements, partnerships, acquisitions, mergers, new developments, and product launches.
Key questions answered
- How feasible is Ankylosing Spondylitis (AS) Market for long-term investment?
- What are influencing factors driving the demand for Ankylosing Spondylitis (AS) near future?
- What is the impact analysis of various factors in the Global Ankylosing Spondylitis (AS) market growth?
- What are the recent trends in the regional market and how successful they are?
- Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America
Browse Trending Reports:
Food And Beverage Mechanical Seals Market
Wavefront Aberrometer Market
Push To Talk Ptt Market
Digital Pet Care Products And Services Market
Phenol Market
Diabetic Neuropathy Market
Mecoprop Market
Herbal Tea Market
Regtech Market
Waterway Third Party Logistics Market
e Tree Metro Ethernet Services Market
Sun Protective Clothing Market
Contemporary Height Adjustable Desk Market
Packaging Suction Cup Market
Liquid Egg Processing Market
Fish Protein Hydrolysate Market
Pediatric Neurology Devices Market
Acute Sinusitis Market
Aquaculture Healthcare Market
Artificial Grass Market
Carbon Dioxide Market
Perfusion Radiology Market
Big Data Analytics In Agriculture Market
Medical Cannabis Based Oil Extract Infused Products Market
Smart Toys Market
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
